Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 39 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 9447144

    MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  2. US 9446048

    Methods for treating leukemia and disorders mediated by CBFβ and RUNX1 proteins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 20, 2016 · Expires Sep 15, 2036

    granted
  3. US 9439875

    Anxiolytic effect of pterostilbene

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  4. US 9441041

    Use of antagonists of the interaction between HIV GP120 and α4β7 integrin

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  5. US 9441022

    Aegyptin and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  6. US 9439979

    Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus type 6 (AAV6) transduction

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  7. US 9441019

    Influenza hemagglutinin protein-based vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  8. US 9441048

    Antibody for 3′-isoLM1 and 3′,6′-iso-LD1 gangliosides

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  9. US 9441050

    High-affinity monoclonal anti-prion antibodies

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 13, 2016 · Expires Sep 8, 2036

    granted
  10. US 9428541

    Substrate reduction therapy

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  11. US 9427476

    Multivalent meningococcal conjugates and methods for preparing conjugates

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted
  12. US 9421254

    Immunostimulatory combinations of TLR ligands and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted
  13. US 9415105

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  14. US 9416190

    Mesothelin antibodies and methods for eliciting potent antitumor activity

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  15. US 9415116

    Compositions and methods for delivering inhibitory oligonucleotides

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  16. US 9408901

    Compositions, methods and uses for dengue virus serotype-4 constructs

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  17. US 9409994

    High-affinity monoclonal antibodies to glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  18. US 9409992

    Mesothelin domain-specific monoclonal antibodies and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  19. US 9409956

    Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  20. US 9408896

    Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 9, 2016 · Expires Aug 4, 2036

    granted
  21. US 9402889

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  22. US 9402820

    Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  23. US 9399672

    Hepatitis C virus neutralizing antibody

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted
  24. US 9394352

    Immunogenic POTE peptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 19, 2016 · Expires Jul 14, 2036

    granted